Overview
An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.
Background
An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.
Indication
For use as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
Associated Conditions
- Breast Cancer
- Breast Cancer, Stage II
- Breast Cancer, Stage III
- Colorectal Cancer
- Hormone-Refractory Prostate Cancer
- Neoplasm of Stomach
- Non-Small Cell Lung Carcinoma
- Ovarian Cancer
- Papillary transitional cell carcinoma of bladder
- Recurrent Superficial Bladder Cancer
- Small Cell Lung Cancer (SCLC)
- Soft Tissue Sarcoma
- Carcinoma in situ of urinary bladder
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2017/09/05 | Phase 2 | Completed | |||
2017/04/21 | Phase 4 | UNKNOWN | Zhejiang University | ||
2017/01/30 | Phase 3 | Active, not recruiting | |||
2017/01/19 | Phase 2 | Recruiting | Groupe Hospitalier Diaconesses Croix Saint-Simon | ||
2017/01/16 | Not Applicable | UNKNOWN | Hebei Medical University Fourth Hospital | ||
2017/01/06 | Phase 3 | Completed | |||
2016/12/30 | Phase 3 | UNKNOWN | Shi Yanxia | ||
2016/12/08 | Phase 1 | UNKNOWN | |||
2016/11/22 | Phase 3 | UNKNOWN | Shanghai Zhongshan Hospital | ||
2016/10/31 | Phase 2 | UNKNOWN | Jinling Hospital, China |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||